Bioactive Lipid Mediators in Cardiopulmonary Pharmacology (Volume 97) (Advances in Pharmacology, Volume 97) (PDF)

Through the desolate landscape of humanity, I’ve been flaunting my wild zeal of a baronet’s life.

Bioactive Lipid Modulators in Cardiopulmonary Pharmaceuticals, Volume 97, provides readers with information about Bioactive Lipid mediators. These mediators participate in a complex array of pathways that control both physiological and pathophysiological responses. Chapters in the new release include Cyclooxygenases and Vascular Function, Cyclooxygenases and Platelet Function, Eicosanoids and Cardiomyopathies, Cytochrome P450 Bioactive Lipids in the heart, Epoxide hydrolase and Leukotoxin in the heart and lungs, the role of cytochrome P450-epoxygenase in the regulation of vascular response, Bioactive Lipids in Hypertension, Cytochrome P450 Metabolites and Angiogenesis, 20-Hydroxyeicosatetraenoic Acid and Vascular Function, and additional.

Other critical sections include Cytochrome P450 Eicosanoids and the Brain, Omega-3 Oxylipids, Resolvins, Lipoxins and inflammation, Endocannabinoids as Bioactive Metabolites, and Oxylipins and Aspirin that exacerbate respiratory disease.

Summarizes the findings of international experts in the field of bioactive lipids.

Concerned with the present, with a focus on the creation of novel therapeutics.

Includes a variety of bioactive lipids derived from COX, LOX or CYP’s metabolism of omega-3 and omega-6 fatty acids.

Publisher : ‎ Academic Press; the first edition ( June 8th, 2023 )

Language ‏ : ‎ English

eBook digital: 462 pages

ISBN-13 ‏: ‎ 0323950 paraphrase> Purchasing options available: online or in store?

ISBN-13 ‏: ‎ 0323950572